[
  {
    "ts": "2026-01-15T12:47:54+00:00",
    "headline": "Dow Jones Futures: Nvidia Chipmaker Taiwan Semiconductor Jumps, Lifting Sector; Goldman Earnings Mixed",
    "summary": "Taiwan Semiconductor beat views and guided higher. Goldman Sachs and Morgan Stanley both beat on earnings.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nvidia-chipmaker-taiwan-semiconductor-earnings-goldman-sachs-morgan-stanley-earnings/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "32cd720f-a5cf-378d-9384-5113843d8e71",
      "content": {
        "id": "32cd720f-a5cf-378d-9384-5113843d8e71",
        "contentType": "STORY",
        "title": "Dow Jones Futures: Nvidia Chipmaker Taiwan Semiconductor Jumps, Lifting Sector; Goldman Earnings Mixed",
        "description": "",
        "summary": "Taiwan Semiconductor beat views and guided higher. Goldman Sachs and Morgan Stanley both beat on earnings.",
        "pubDate": "2026-01-15T12:47:54Z",
        "displayTime": "2026-01-15T12:47:54Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/32cd720f-a5cf-378d-9384-5113843d8e71/dow-jones-futures-nvidia.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/b78680df44aa2754ba3b085acd1e2fd2",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.p8V8Vta_miku1keGRvBbg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/b78680df44aa2754ba3b085acd1e2fd2.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FBLfCRBfrwD.5UUUL7FgLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/b78680df44aa2754ba3b085acd1e2fd2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nvidia-chipmaker-taiwan-semiconductor-earnings-goldman-sachs-morgan-stanley-earnings/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "TSM"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "PEN"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "SHOP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T12:46:59+00:00",
    "headline": "Boston Scientific to Acquire Penumbra in $14.5 Billion Cash-Stock Deal",
    "summary": "Boston Scientific (BSX) said Thursday it has agreed to acquire Penumbra (PEN) in a cash and stock de",
    "url": "https://finance.yahoo.com/news/boston-scientific-acquire-penumbra-14-124659334.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "1aba826b-673b-3905-a415-c2c62d1c9cdb",
      "content": {
        "id": "1aba826b-673b-3905-a415-c2c62d1c9cdb",
        "contentType": "STORY",
        "title": "Boston Scientific to Acquire Penumbra in $14.5 Billion Cash-Stock Deal",
        "description": "",
        "summary": "Boston Scientific (BSX) said Thursday it has agreed to acquire Penumbra (PEN) in a cash and stock de",
        "pubDate": "2026-01-15T12:46:59Z",
        "displayTime": "2026-01-15T12:46:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-acquire-penumbra-14-124659334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-acquire-penumbra-14-124659334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T12:25:31+00:00",
    "headline": "Boston Scientific Will Buy Penumbra In $14.5 Billion Medtech Deal",
    "summary": "Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock jumped. Boston Scientific tumbled.",
    "url": "https://www.investors.com/news/technology/boston-scientific-will-buy-penumbra-14-5-billion-medtech-deal/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "0ec7e465-1c2f-3b51-9633-93cc08411422",
      "content": {
        "id": "0ec7e465-1c2f-3b51-9633-93cc08411422",
        "contentType": "STORY",
        "title": "Boston Scientific Will Buy Penumbra In $14.5 Billion Medtech Deal",
        "description": "",
        "summary": "Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock jumped. Boston Scientific tumbled.",
        "pubDate": "2026-01-15T12:25:31Z",
        "displayTime": "2026-01-15T12:25:31Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0ec7e465-1c2f-3b51-9633-93cc08411422/boston-scientific-will-buy.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/f45996b6705cbb044c06bc80da47329c",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8vn7M2CgxocQUMk.YQ9qsw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f45996b6705cbb044c06bc80da47329c.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3w2xDqki9y1_lQTn0DhbqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/f45996b6705cbb044c06bc80da47329c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/boston-scientific-will-buy-penumbra-14-5-billion-medtech-deal/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T12:22:02+00:00",
    "headline": "Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade",
    "summary": "Jan 15 (Reuters) - Boston Scientific is buying medical equipment maker Penumbra in a deal valued at about $14.5 billion, to expand its vascular pipeline.",
    "url": "https://finance.yahoo.com/news/factbox-major-deals-involving-u-122202362.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "98831ded-5316-3639-8b32-bf5b84c462f3",
      "content": {
        "id": "98831ded-5316-3639-8b32-bf5b84c462f3",
        "contentType": "STORY",
        "title": "Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade",
        "description": "",
        "summary": "Jan 15 (Reuters) - Boston Scientific is buying medical equipment maker Penumbra in a deal valued at about $14.5 billion, to expand its vascular pipeline.",
        "pubDate": "2026-01-15T12:22:02Z",
        "displayTime": "2026-01-15T12:22:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/factbox-major-deals-involving-u-122202362.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/factbox-major-deals-involving-u-122202362.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PEN"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "EXAS"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T12:13:41+00:00",
    "headline": "Boston Scientific to buy Penumbra in $14.5 billion deal",
    "summary": "Jan 15 () - Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular pipeline.",
    "url": "https://finance.yahoo.com/news/boston-scientific-buy-penumbra-deal-120734385.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "61a57a47-7e7d-347c-9620-386089c01f41",
      "content": {
        "id": "61a57a47-7e7d-347c-9620-386089c01f41",
        "contentType": "STORY",
        "title": "Boston Scientific to buy Penumbra in $14.5 billion deal",
        "description": "",
        "summary": "Jan 15 () - Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular pipeline.",
        "pubDate": "2026-01-15T12:13:41Z",
        "displayTime": "2026-01-15T12:13:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/b814543855a0109de82fa20a8674cd3a",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qZHTRSIaM3x.pO6YD5AUSw--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b814543855a0109de82fa20a8674cd3a.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZeJ7erUbF7FMhRyUrn8j1w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b814543855a0109de82fa20a8674cd3a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-buy-penumbra-deal-120734385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-buy-penumbra-deal-120734385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T12:00:00+00:00",
    "headline": "Boston Scientific announces agreement to acquire Penumbra, Inc.",
    "summary": "Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion.i",
    "url": "https://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-120000564.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "a69f1609-d01c-347b-bec7-3e5e73769190",
      "content": {
        "id": "a69f1609-d01c-347b-bec7-3e5e73769190",
        "contentType": "STORY",
        "title": "Boston Scientific announces agreement to acquire Penumbra, Inc.",
        "description": "",
        "summary": "Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion.i",
        "pubDate": "2026-01-15T12:00:00Z",
        "displayTime": "2026-01-15T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888",
          "originalWidth": 400,
          "originalHeight": 209,
          "caption": "Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bqyalFkM.p2vF1LWkaMoDA--~B/aD0yMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888.cf.webp",
              "width": 400,
              "height": 209,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Oi.RxhAOmrA0KHLwcormRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-120000564.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-announces-agreement-acquire-120000564.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T13:29:23+00:00",
    "headline": "Exchange-Traded Funds, Equity Futures Higher Pre-Bell Buoyed by Taiwan Semiconductor Manufacturing Guidance",
    "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively trad",
    "url": "https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-132923231.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "db0b097b-709c-319b-98f5-602a5b1641f5",
      "content": {
        "id": "db0b097b-709c-319b-98f5-602a5b1641f5",
        "contentType": "STORY",
        "title": "Exchange-Traded Funds, Equity Futures Higher Pre-Bell Buoyed by Taiwan Semiconductor Manufacturing Guidance",
        "description": "",
        "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively trad",
        "pubDate": "2026-01-15T13:29:23Z",
        "displayTime": "2026-01-15T13:29:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-132923231.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-132923231.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TSM"
            },
            {
              "symbol": "QQQ"
            },
            {
              "symbol": "SPY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "BTC-USD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T12:33:44+00:00",
    "headline": "Stocks to Watch Thursday: Boston Scientific, Goldman Sachs, TSMC",
    "summary": "↗️ BlackRock (BLK): The world's biggest money manager posted better-than-expected adjusted earnings per share, although its quarterly profit fell. Shares rose around 2% in premarket trading. ↘️ Goldman Sachs (GS): The Wall Street bank's quarterly earnings per share topped forecasts and Goldman also posted record annual revenue.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-15-2026/card/stocks-to-watch-thursday-tsmc-goldman-sachs-nvidia-alibaba-Q7S472ia1M1VgD5wREeq?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "954672e8-87c3-3fc8-9274-7cac813f1231",
      "content": {
        "id": "954672e8-87c3-3fc8-9274-7cac813f1231",
        "contentType": "STORY",
        "title": "Stocks to Watch Thursday: Boston Scientific, Goldman Sachs, TSMC",
        "description": "",
        "summary": "↗️ BlackRock (BLK): The world's biggest money manager posted better-than-expected adjusted earnings per share, although its quarterly profit fell. Shares rose around 2% in premarket trading. ↘️ Goldman Sachs (GS): The Wall Street bank's quarterly earnings per share topped forecasts and Goldman also posted record annual revenue.",
        "pubDate": "2026-01-15T12:33:44Z",
        "displayTime": "2026-01-15T12:33:44Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/954672e8-87c3-3fc8-9274-7cac813f1231/stocks-to-watch-thursday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/4c8aa591e6485bb9d51e8939035026aa",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ck2M6fYgpUqrLNZsTd.Bmw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/4c8aa591e6485bb9d51e8939035026aa.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bSO79XwXhhd2kh8iDgusfQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/4c8aa591e6485bb9d51e8939035026aa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-15-2026/card/stocks-to-watch-thursday-tsmc-goldman-sachs-nvidia-alibaba-Q7S472ia1M1VgD5wREeq?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "CFRHF"
            },
            {
              "symbol": "CFRUY"
            },
            {
              "symbol": "ASMLF"
            },
            {
              "symbol": "TSM"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "ASML"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T12:25:00+00:00",
    "headline": "Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock",
    "summary": "Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.",
    "url": "https://www.wsj.com/business/deals/boston-scientific-to-buy-penumbra-for-15-billion-in-cash-stock-d42455c8?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "0bcd81a7-b2ed-3a5c-bdc3-d6dac7ae6931",
      "content": {
        "id": "0bcd81a7-b2ed-3a5c-bdc3-d6dac7ae6931",
        "contentType": "STORY",
        "title": "Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock",
        "description": "",
        "summary": "Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.",
        "pubDate": "2026-01-15T12:25:00Z",
        "displayTime": "2026-01-15T12:25:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0bcd81a7-b2ed-3a5c-bdc3-d6dac7ae6931/boston-scientific-to-buy.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/230fe3ffa4eb1a97229cc51a57a08650",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fU_BhC1H_Ar_3bVnzXSgYA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/230fe3ffa4eb1a97229cc51a57a08650.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9o0NyCGGQylBGPDScuJs8Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/230fe3ffa4eb1a97229cc51a57a08650.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/business/deals/boston-scientific-to-buy-penumbra-for-15-billion-in-cash-stock-d42455c8?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T14:23:03+00:00",
    "headline": "BlackRock earnings, Spotify to raise premium price in the US",
    "summary": "Morning Brief Host Julie Hyman tracks several of the day's top trending stock tickers, including BlackRock (BLK), Boston Scientific's (BSX) deal to acquire Penumbra (PEN), and Spotify (SPOT). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Morning Brief.",
    "url": "https://finance.yahoo.com/video/blackrock-earnings-spotify-raise-premium-142303492.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "8762eb2d-cc7f-3ee0-a04d-e424c9546924",
      "content": {
        "id": "8762eb2d-cc7f-3ee0-a04d-e424c9546924",
        "contentType": "VIDEO",
        "title": "BlackRock earnings, Spotify to raise premium price in the US",
        "description": "<p>Morning Brief Host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/julie-hyman/?.tsrc=fin-srch\">Julie Hyman</a> tracks several of the day's top trending stock tickers, including BlackRock (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/BLK\">BLK</a>), Boston Scientific's (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/BSX\">BSX</a>) deal to acquire Penumbra (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/PEN\">PEN</a>), and Spotify (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/SPOT\">SPOT</a>).</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/videos/series/morning-brief/\">Morning Brief</a>.</p>",
        "summary": "Morning Brief Host Julie Hyman tracks several of the day's top trending stock tickers, including BlackRock (BLK), Boston Scientific's (BSX) deal to acquire Penumbra (PEN), and Spotify (SPOT). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Morning Brief.",
        "pubDate": "2026-01-15T14:23:03Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/880ef3a0-f21d-11f0-b9dd-716295810be2",
          "originalWidth": 4936,
          "originalHeight": 2779,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iNNoCGK5BkBRqldTjLYbYQ--~B/aD0yNzc5O3c9NDkzNjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/880ef3a0-f21d-11f0-b9dd-716295810be2.cf.webp",
              "width": 4936,
              "height": 2779,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iv9NPazGtAOMSPbqqXpw5Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/880ef3a0-f21d-11f0-b9dd-716295810be2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/blackrock-earnings-spotify-raise-premium-142303492.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/blackrock-earnings-spotify-raise-premium-142303492.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "BLK"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T14:22:04+00:00",
    "headline": "Sector Update: Health Care Stocks Mixed Pre-Bell Thursday",
    "summary": "Health care stocks were mixed pre-bell Thursday, with the State Street Health Care Select Sector SPD",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-mixed-142204212.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "f5c8fcb0-235d-3e38-8b88-13cd65ba57a7",
      "content": {
        "id": "f5c8fcb0-235d-3e38-8b88-13cd65ba57a7",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Mixed Pre-Bell Thursday",
        "description": "",
        "summary": "Health care stocks were mixed pre-bell Thursday, with the State Street Health Care Select Sector SPD",
        "pubDate": "2026-01-15T14:22:04Z",
        "displayTime": "2026-01-15T14:22:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-mixed-142204212.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-mixed-142204212.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PEN"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "IRON"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T14:01:23+00:00",
    "headline": "Strong Chipmaker Earnings Lift Technology Sector, With US Equity Futures Mostly Higher Pre-Bell",
    "summary": "US equity futures were mostly higher ahead of Thursday's opening bell, with futures of technology-he",
    "url": "https://finance.yahoo.com/news/strong-chipmaker-earnings-lift-technology-140123287.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "62d5b2a4-73c8-3343-bbd6-5ea2b4e55b3a",
      "content": {
        "id": "62d5b2a4-73c8-3343-bbd6-5ea2b4e55b3a",
        "contentType": "STORY",
        "title": "Strong Chipmaker Earnings Lift Technology Sector, With US Equity Futures Mostly Higher Pre-Bell",
        "description": "",
        "summary": "US equity futures were mostly higher ahead of Thursday's opening bell, with futures of technology-he",
        "pubDate": "2026-01-15T14:01:23Z",
        "displayTime": "2026-01-15T14:01:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/strong-chipmaker-earnings-lift-technology-140123287.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/strong-chipmaker-earnings-lift-technology-140123287.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "RILY"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            },
            {
              "symbol": "TSM"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T13:55:54+00:00",
    "headline": "Boston Scientific to Acquire Penumbra in $14.5 Billion Deal",
    "summary": "Boston Scientific (BSX) on Thursday agreed to acquire medical device company Penumbra (PEN) in a cas",
    "url": "https://finance.yahoo.com/news/boston-scientific-acquire-penumbra-14-135554369.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "3d8f7409-6d7b-3c6e-ae2c-af55e587a36c",
      "content": {
        "id": "3d8f7409-6d7b-3c6e-ae2c-af55e587a36c",
        "contentType": "STORY",
        "title": "Boston Scientific to Acquire Penumbra in $14.5 Billion Deal",
        "description": "",
        "summary": "Boston Scientific (BSX) on Thursday agreed to acquire medical device company Penumbra (PEN) in a cas",
        "pubDate": "2026-01-15T13:55:54Z",
        "displayTime": "2026-01-15T13:55:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/3c96472349e25119e148a6930f7f7e2d",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "Boston Scientific BSX.jpg - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dWO8A0eEzXePMeJdR1iuCA--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/3c96472349e25119e148a6930f7f7e2d.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uzl0VT7yW1Caxh_luUTXeQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/3c96472349e25119e148a6930f7f7e2d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-acquire-penumbra-14-135554369.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-acquire-penumbra-14-135554369.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T13:38:05+00:00",
    "headline": "Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down",
    "summary": "Investing.com -- Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra (NYSE:PEN) in a transaction valued at roughly $14.5 billion, strengthening its position in cardiovascular devices.",
    "url": "https://finance.yahoo.com/news/penumbra-surges-news-14-5-133805340.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "ecc09c45-afc7-3a2b-9e44-37fd96c30eab",
      "content": {
        "id": "ecc09c45-afc7-3a2b-9e44-37fd96c30eab",
        "contentType": "STORY",
        "title": "Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down",
        "description": "",
        "summary": "Investing.com -- Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra (NYSE:PEN) in a transaction valued at roughly $14.5 billion, strengthening its position in cardiovascular devices.",
        "pubDate": "2026-01-15T13:38:05Z",
        "displayTime": "2026-01-15T13:38:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/penumbra-surges-news-14-5-133805340.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/penumbra-surges-news-14-5-133805340.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T14:45:12+00:00",
    "headline": "Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock",
    "summary": "↗️ BlackRock (BLK): The world's biggest money manager posted better-than-expected adjusted earnings per share, although its quarterly profit fell. Shares rose around 5% Thursday morning. ↗️ Goldman Sachs (GS): The Wall Street bank's quarterly earnings per share topped forecasts and Goldman also posted record annual revenue.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-15-2026/card/stocks-to-watch-thursday-tsmc-goldman-sachs-nvidia-alibaba-Q7S472ia1M1VgD5wREeq?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "954672e8-87c3-3fc8-9274-7cac813f1231",
      "content": {
        "id": "954672e8-87c3-3fc8-9274-7cac813f1231",
        "contentType": "STORY",
        "title": "Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock",
        "description": "",
        "summary": "↗️ BlackRock (BLK): The world's biggest money manager posted better-than-expected adjusted earnings per share, although its quarterly profit fell. Shares rose around 5% Thursday morning. ↗️ Goldman Sachs (GS): The Wall Street bank's quarterly earnings per share topped forecasts and Goldman also posted record annual revenue.",
        "pubDate": "2026-01-15T14:45:12Z",
        "displayTime": "2026-01-15T14:45:12Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/954672e8-87c3-3fc8-9274-7cac813f1231/stocks-to-watch-thursday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7ce48b2a62d15fa0a114ce3ba7e9f394",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ng3.KrERBoC5.oEnET94Wg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7ce48b2a62d15fa0a114ce3ba7e9f394.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xcX.7eJ_Eok_VohM_YOwAA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7ce48b2a62d15fa0a114ce3ba7e9f394.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-15-2026/card/stocks-to-watch-thursday-tsmc-goldman-sachs-nvidia-alibaba-Q7S472ia1M1VgD5wREeq?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "TSMWF"
            },
            {
              "symbol": "MS"
            },
            {
              "symbol": "MS-PQ"
            },
            {
              "symbol": "OCUL"
            },
            {
              "symbol": "GS"
            },
            {
              "symbol": "ASML"
            },
            {
              "symbol": "BLK"
            },
            {
              "symbol": "PEN"
            },
            {
              "symbol": "TSM"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T13:45:00+00:00",
    "headline": "Penumbra Stock Jumps. It’s Being Bought by Boston Scientific for $14.5 Billion.",
    "summary": "Boston Scientific  has agreed to acquire  Penumbra  in a cash-and-stock deal worth $14.5 billion.  The addition of  Penumbra  which makes mechanical thrombectomy products for vascular procedures, expands  Boston Scientific’s  vascular medicine business.  Penumbra shares soared 13% to $354.66 on Thursday.",
    "url": "https://www.barrons.com/articles/penumbra-stock-boston-scientific-acquisition-55436ca4?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "024fbeea-a085-3453-a34e-105bbf45bded",
      "content": {
        "id": "024fbeea-a085-3453-a34e-105bbf45bded",
        "contentType": "STORY",
        "title": "Penumbra Stock Jumps. It’s Being Bought by Boston Scientific for $14.5 Billion.",
        "description": "",
        "summary": "Boston Scientific  has agreed to acquire  Penumbra  in a cash-and-stock deal worth $14.5 billion.  The addition of  Penumbra  which makes mechanical thrombectomy products for vascular procedures, expands  Boston Scientific’s  vascular medicine business.  Penumbra shares soared 13% to $354.66 on Thursday.",
        "pubDate": "2026-01-15T13:45:00Z",
        "displayTime": "2026-01-15T13:45:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/024fbeea-a085-3453-a34e-105bbf45bded/penumbra-stock-jumps-it%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/73b8b8172c88ecd96e101deac806465f",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Uz1uBucZIAs0jd2NwE142Q--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/73b8b8172c88ecd96e101deac806465f.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ROfrMstgxt44uKvkXoC36Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/73b8b8172c88ecd96e101deac806465f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/penumbra-stock-boston-scientific-acquisition-55436ca4?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T13:24:00+00:00",
    "headline": "BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies",
    "summary": "Boston Scientific stock may rebound after agreeing to buy Valencia Technologies, adding the FDA-approved eCoin ITNS device to expand its Urology portfolio.",
    "url": "https://finance.yahoo.com/news/bsx-stock-may-gain-newly-132400268.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "73f58137-4608-3752-9132-c43c348f343e",
      "content": {
        "id": "73f58137-4608-3752-9132-c43c348f343e",
        "contentType": "STORY",
        "title": "BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies",
        "description": "",
        "summary": "Boston Scientific stock may rebound after agreeing to buy Valencia Technologies, adding the FDA-approved eCoin ITNS device to expand its Urology portfolio.",
        "pubDate": "2026-01-15T13:24:00Z",
        "displayTime": "2026-01-15T13:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bsx-stock-may-gain-newly-132400268.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bsx-stock-may-gain-newly-132400268.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVST"
            },
            {
              "symbol": "STE"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T16:03:34+00:00",
    "headline": "Lightning Flashes As Boston Scientific Takes Over Penumbra For $14.5 Billion",
    "summary": "Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock jumped. Boston Scientific tumbled.",
    "url": "https://www.investors.com/news/technology/boston-scientific-will-buy-penumbra-14-5-billion-medtech-deal/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "0ec7e465-1c2f-3b51-9633-93cc08411422",
      "content": {
        "id": "0ec7e465-1c2f-3b51-9633-93cc08411422",
        "contentType": "STORY",
        "title": "Lightning Flashes As Boston Scientific Takes Over Penumbra For $14.5 Billion",
        "description": "",
        "summary": "Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock jumped. Boston Scientific tumbled.",
        "pubDate": "2026-01-15T16:03:34Z",
        "displayTime": "2026-01-15T16:03:34Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0ec7e465-1c2f-3b51-9633-93cc08411422/lightning-flashes-as-boston.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/a99920be6e7ddf779a73bc4118768521",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8F4mroPZ_y_G8qqsItXPUg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/a99920be6e7ddf779a73bc4118768521.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lvtS_QBC.f1lEYlq1uDCJQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/a99920be6e7ddf779a73bc4118768521.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/boston-scientific-will-buy-penumbra-14-5-billion-medtech-deal/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PEN"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T15:17:03+00:00",
    "headline": "Boston Scientific Agrees to Buy Penumbra in $14.6 Billion Cardiovascular Deal",
    "summary": "The cash-and-stock transaction values Penumbra at $374 per share and is expected to close later this year.",
    "url": "https://finance.yahoo.com/news/boston-scientific-agrees-buy-penumbra-151703410.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "c73dffde-6f42-399f-97f2-8ffcdaa1ea95",
      "content": {
        "id": "c73dffde-6f42-399f-97f2-8ffcdaa1ea95",
        "contentType": "STORY",
        "title": "Boston Scientific Agrees to Buy Penumbra in $14.6 Billion Cardiovascular Deal",
        "description": "",
        "summary": "The cash-and-stock transaction values Penumbra at $374 per share and is expected to close later this year.",
        "pubDate": "2026-01-15T15:17:03Z",
        "displayTime": "2026-01-15T15:17:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/edde0f01edfee2c1750229420fb654c6",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SMPq1J94qggCzWz.q5Rn_A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/edde0f01edfee2c1750229420fb654c6.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_tEi8MLrrsU5ANPy9Hf03A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/edde0f01edfee2c1750229420fb654c6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-agrees-buy-penumbra-151703410.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-agrees-buy-penumbra-151703410.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T14:42:00+00:00",
    "headline": "Is it Apt to Retain HAE Stock in Your Portfolio for Now?",
    "summary": "Haemonetics' plasma and hemostasis franchises show solid growth potential, but macro headwinds and competition cloud the near-term outlook.",
    "url": "https://finance.yahoo.com/news/apt-retain-hae-stock-portfolio-144200359.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "976841d6-e112-399a-a6e3-76d84f95a2bb",
      "content": {
        "id": "976841d6-e112-399a-a6e3-76d84f95a2bb",
        "contentType": "STORY",
        "title": "Is it Apt to Retain HAE Stock in Your Portfolio for Now?",
        "description": "",
        "summary": "Haemonetics' plasma and hemostasis franchises show solid growth potential, but macro headwinds and competition cloud the near-term outlook.",
        "pubDate": "2026-01-15T14:42:00Z",
        "displayTime": "2026-01-15T14:42:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Z6CaNjdpI8OLeo5.Ul_eA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o6kyOwY40meLORq99yf8XA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/apt-retain-hae-stock-portfolio-144200359.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/apt-retain-hae-stock-portfolio-144200359.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HAE"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "NVST"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T14:42:00+00:00",
    "headline": "Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It?",
    "summary": "PAHC shares are up 90.9% this year, fueled by surging vaccine sales, new Brazil capacity and rapid growth across emerging markets.",
    "url": "https://finance.yahoo.com/news/phibro-animal-health-stock-climbs-144200939.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a270750c-dfc8-3e5a-98e8-ff67ec610e6f",
      "content": {
        "id": "a270750c-dfc8-3e5a-98e8-ff67ec610e6f",
        "contentType": "STORY",
        "title": "Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It?",
        "description": "",
        "summary": "PAHC shares are up 90.9% this year, fueled by surging vaccine sales, new Brazil capacity and rapid growth across emerging markets.",
        "pubDate": "2026-01-15T14:42:00Z",
        "displayTime": "2026-01-15T14:42:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Z6CaNjdpI8OLeo5.Ul_eA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o6kyOwY40meLORq99yf8XA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/phibro-animal-health-stock-climbs-144200939.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/phibro-animal-health-stock-climbs-144200939.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PAHC"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PBH"
            },
            {
              "symbol": "CRL"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T10:23:03+00:00",
    "headline": "Boston Scientific to acquire Penumbra for $14.5B",
    "summary": "With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.",
    "url": "https://www.medtechdive.com/news/boston-scientific-acquire-penumbra/809734/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "a20b4686-f34e-3cb2-b5eb-597e11c59707",
      "content": {
        "id": "a20b4686-f34e-3cb2-b5eb-597e11c59707",
        "contentType": "STORY",
        "title": "Boston Scientific to acquire Penumbra for $14.5B",
        "description": "",
        "summary": "With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.",
        "pubDate": "2026-01-15T10:23:03Z",
        "displayTime": "2026-01-15T10:23:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/40cb258bab3d29ec0583b5174afdb632",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Michael F. Mahoney, CEO of Boston Scientific.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Wink0Nlxi3xqKO8y9MtJQg--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/40cb258bab3d29ec0583b5174afdb632.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T0ss1ZlE5Nc8Qa0hoINxGQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/40cb258bab3d29ec0583b5174afdb632.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/boston-scientific-acquire-penumbra/809734/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-acquire-penumbra-14-102303351.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T15:53:00+00:00",
    "headline": "Masimo Stock Declines Despite Solid Preliminary Q4 Revenues",
    "summary": "MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core healthcare momentum.",
    "url": "https://finance.yahoo.com/news/masimo-stock-declines-despite-solid-155300295.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3e0fdcb1-2c94-3248-a0e9-a655302ab428",
      "content": {
        "id": "3e0fdcb1-2c94-3248-a0e9-a655302ab428",
        "contentType": "STORY",
        "title": "Masimo Stock Declines Despite Solid Preliminary Q4 Revenues",
        "description": "",
        "summary": "MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core healthcare momentum.",
        "pubDate": "2026-01-15T15:53:00Z",
        "displayTime": "2026-01-15T15:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/35c3104750059d60e5b1f7ecb072b5d1",
          "originalWidth": 620,
          "originalHeight": 379,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VavepHRg1iY8QTjQB_FsJA--~B/aD0zNzk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/35c3104750059d60e5b1f7ecb072b5d1.cf.webp",
              "width": 620,
              "height": 379,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ja47MGH5StF9x0Gd3.AYWQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/35c3104750059d60e5b1f7ecb072b5d1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/masimo-stock-declines-despite-solid-155300295.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/masimo-stock-declines-despite-solid-155300295.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MASI"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T15:37:00+00:00",
    "headline": "Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now",
    "summary": "QDEL's decent Q3 2025 results and expanding diagnostics portfolio support near-term growth despite respiratory reliance and payer risks.",
    "url": "https://finance.yahoo.com/news/reasons-retain-quidelortho-stock-portfolio-153700916.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a80df643-0410-397e-bad5-235f9e66f7b2",
      "content": {
        "id": "a80df643-0410-397e-bad5-235f9e66f7b2",
        "contentType": "STORY",
        "title": "Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now",
        "description": "",
        "summary": "QDEL's decent Q3 2025 results and expanding diagnostics portfolio support near-term growth despite respiratory reliance and payer risks.",
        "pubDate": "2026-01-15T15:37:00Z",
        "displayTime": "2026-01-15T15:37:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5efl.hfUE9GqHAAzVZOyrQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZSi1jC0ojY5JbN8IL4CqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/reasons-retain-quidelortho-stock-portfolio-153700916.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/reasons-retain-quidelortho-stock-portfolio-153700916.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "QDEL"
            },
            {
              "symbol": "STE"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T15:35:20+00:00",
    "headline": "Stocks to Watch Thursday: Penumbra, BlackRock, Goldman Sachs",
    "summary": "↗️ BlackRock (BLK): The world's biggest money manager posted better-than-expected adjusted earnings per share, although its quarterly profit fell. Shares rose around 5% Thursday morning. ↗️ Goldman Sachs (GS): The bank's quarterly EPS also topped forecasts and Goldman also posted record annual revenue.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-15-2026/card/stocks-to-watch-thursday-tsmc-goldman-sachs-nvidia-alibaba-Q7S472ia1M1VgD5wREeq?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "954672e8-87c3-3fc8-9274-7cac813f1231",
      "content": {
        "id": "954672e8-87c3-3fc8-9274-7cac813f1231",
        "contentType": "STORY",
        "title": "Stocks to Watch Thursday: Penumbra, BlackRock, Goldman Sachs",
        "description": "",
        "summary": "↗️ BlackRock (BLK): The world's biggest money manager posted better-than-expected adjusted earnings per share, although its quarterly profit fell. Shares rose around 5% Thursday morning. ↗️ Goldman Sachs (GS): The bank's quarterly EPS also topped forecasts and Goldman also posted record annual revenue.",
        "pubDate": "2026-01-15T15:35:20Z",
        "displayTime": "2026-01-15T15:35:20Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/954672e8-87c3-3fc8-9274-7cac813f1231/stocks-to-watch-thursday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7ce48b2a62d15fa0a114ce3ba7e9f394",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ng3.KrERBoC5.oEnET94Wg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7ce48b2a62d15fa0a114ce3ba7e9f394.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xcX.7eJ_Eok_VohM_YOwAA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7ce48b2a62d15fa0a114ce3ba7e9f394.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-15-2026/card/stocks-to-watch-thursday-tsmc-goldman-sachs-nvidia-alibaba-Q7S472ia1M1VgD5wREeq?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ASMLF"
            },
            {
              "symbol": "MS"
            },
            {
              "symbol": "MS-PQ"
            },
            {
              "symbol": "OCUL"
            },
            {
              "symbol": "GS"
            },
            {
              "symbol": "TSMWF"
            },
            {
              "symbol": "ASML"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "BLK"
            },
            {
              "symbol": "PEN"
            },
            {
              "symbol": "TSM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-15T15:35:00+00:00",
    "headline": "PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research",
    "summary": "PACB stock jumps as HiFi whole-genome sequencing becomes first-line in major SUDC research, highlighting adoption momentum.",
    "url": "https://finance.yahoo.com/news/pacbio-stock-hifi-sequencing-adoption-153500395.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "78cb29ac-a8bd-36fd-85be-d4b381f2ed24",
      "content": {
        "id": "78cb29ac-a8bd-36fd-85be-d4b381f2ed24",
        "contentType": "STORY",
        "title": "PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research",
        "description": "",
        "summary": "PACB stock jumps as HiFi whole-genome sequencing becomes first-line in major SUDC research, highlighting adoption momentum.",
        "pubDate": "2026-01-15T15:35:00Z",
        "displayTime": "2026-01-15T15:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EzN04L.MG5n2SiOn76bXjg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1EIdoTL1xBchT1nrSboC2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pacbio-stock-hifi-sequencing-adoption-153500395.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pacbio-stock-hifi-sequencing-adoption-153500395.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "STE"
            },
            {
              "symbol": "PACB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]